Skip to content

Prevalence of different parasomnias in the general Norwegian population, and their association with insomnia, anxiety, and depression. A cross-sectional web-panel survey

Erlend Haarr Drugli, Oskar Emil Lehmann, Ståle Pallesen, Ingvild West Saxvig, Siri Waage, Bjørn Bjorvatn

Frontiers in Sleep April 23, 2026 DOI: 10.3389/frsle.2026.1806980 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Cross-sectional online survey Peer reviewed
Sample size 1,002
Population General Norwegian adult population drawn from a national web panel
Measures Bergen Insomnia Scale, Patient Health Questionnaire-4
Topics Anxiety Depression
Key findings Parasomnias were commonly reported, with lifetime prevalence ranging from 2.3% (sleep-related eating disorder) to 47.2% (nightmares) and current prevalence from 1.0% (injuring somebody else during sleep) to 33.1% (nightmares). Insomnia, anxiety, and depression were associated with most parasomnias, such as nightmares with anxiety (OR 1.58; CI 1.42-1.74). Parasomnias were more common in younger participants, with few sex differences.

Abstract

Objective: To estimate the prevalence of various parasomnias in the general Norwegian adult population and explore their associations with insomnia, anxiety, and depression.

Methods: A cross-sectional online survey was conducted in September 2024 among 1002 adults (50.7% male, mean age 50.3), drawn from a large population-based sample from a national web panel. Participants reported lifetime and past 3-month (current) prevalence of eleven different parasomnias, including both NREM- and REM-related subtypes. Validated instruments assessed insomnia (Bergen Insomnia Scale), anxiety and depression (Patient Health Questionnaire-4). Associations were analyzed using chi-square tests and logistic regressions, adjusting for age, sex, educational level, and circadian preference. Response rate was 19.8%.

Results: Lifetime prevalence of the parasomnias ranged from 2.3% (sleep-related eating disorder) to 47.2% (nightmares), while current prevalence ranged from 1.0% (injured somebody else during sleep) to 33.1% (nightmares). Insomnia, anxiety, and depression were associated with most of the parasomnias [e.g., nightmares-anxiety (OR 1.58; CI 1.42-1.74)]. Parasomnias were more common in younger participants, while sex differences were few.

Conclusion: Many of the parasomnias were commonly reported and strongly associated with insomnia and mental health symptoms. These findings underscore the need for increased clinical awareness and further research on parasomnias.

Comparable studies

Other cross-sectional and survey studies on anxiety, most cited first.

Study Year Design Participants
Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety. International sample of people who reported having used a psychedelic 2020 Cross-sectional survey n = 985
The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms Internet survey respondents reporting challenging experiences with psilocybin 2016 Questionnaire development and validation
Psychedelics and Mental Health: A Population Study Adult population in the United States 2013 Cross-sectional survey n = 130,152
Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users Ecstasy users who participated in a WWW study of recreational drug use 2002 Cross-sectional survey n = 282
5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety. Adults who used 5-MeO-DMT in a group setting with structured procedures 2019 Cross-sectional survey n = 362

Citations in the library

Explore topics